Journal Article Summary
The article investigates the relationship between aspirin prescriptions and mortality rates among COVID-19 patients within the Veterans Health Administration (VA). This topic is significant as it explores how a common medication, known for its anti-inflammatory and antithrombotic properties, might influence outcomes in a population at higher risk for severe COVID-19 complications. Given the ongoing challenges posed by the pandemic, understanding potential treatment options that could reduce mortality is crucial for improving patient care.
The study analyzed data from over 35,000 veterans who tested positive for COVID-19, focusing on those who had been prescribed aspirin prior to their diagnosis. Researchers used statistical methods to compare mortality rates between patients who received aspirin and those who did not, adjusting for various health factors. The findings indicated that veterans with a prior aspirin prescription had significantly lower mortality rates at both 14 and 30 days after diagnosis, suggesting that aspirin may play a protective role in this context.
However, the study has limitations, including its retrospective design, which means it can only show correlation rather than causation. Additionally, the results may not be generalizable to all populations, as the study primarily involved older male veterans with specific health profiles. Patients should consult their healthcare providers before making any changes to their medication regimens, especially considering potential risks associated with aspirin use, such as bleeding disorders.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Osborne Thomas F., Veigulis Zachary P., Arreola David M., Mahajan Satish M., Röösli Eliane, Curtin Catherine M.. Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration. PLoS ONE 2021. DOI: 10.1371/journal.pone.0246825. PMID: 33571280. PMCID: PMC7877611.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
